Insulin-like growth factors: Ligands, binding proteins, and receptors-Reference-Cited by-同舟云学术

Insulin-like growth factors: Ligands, binding proteins, and receptors

Published:2021-10 Issue: Volume:52 Page:101245
ISSN:2212-8778
Container-title:Molecular Metabolism
language:en
Short-container-title:Molecular Metabolism

Author:

LeRoith Derek,Holly Jeff M.P.,Forbes Briony E.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference186 articles.

1. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro;Salmon;The Journal of Laboratory and Clinical Medicine,1957

2. Glucose-regulated protein 94 (GRP94): a novel regulator of insulin-like growth factor production;Argon;Cells,2020

3. Structures of insect Imp-L2 suggest an alternative strategy for regulating the bioavailability of insulin-like hormones;Roed;Nature Communications,2018

4. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: lessons from mouse models;Yakar;Growth Hormone & IGF Research,2016

5. IGF-I is required for normal embryonic growth in mice;Powell-Braxton;Genes & Development,1993

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma;Clinical Genitourinary Cancer;2024-12

2. Role of bovine colostrum against various diseases;Food Bioscience;2024-10

3. Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

4. Insulin-Like Growth Factor Signaling in Alzheimer’s Disease: Pathophysiology and Therapeutic Strategies;Molecular Neurobiology;2024-09-06

5. Valsartan as a prophylactic treatment against breast cancer development and niche activation: What molecular sequels follow chronic AT-1R blockade?;Life Sciences;2024-09